Skip to main content
Journal of Virology logoLink to Journal of Virology
. 1996 Feb;70(2):1296–1300. doi: 10.1128/jvi.70.2.1296-1300.1996

Infection of primary human fetal astrocytes by human herpesvirus 6.

J He 1, M McCarthy 1, Y Zhou 1, B Chandran 1, C Wood 1
PMCID: PMC189947  PMID: 8551599

Abstract

Human herpesvirus 6 (HHV-6) is a lymphotropic betaherpesvirus which productively infects human CD4+ T cells and monocytes. HHV-6 is the etiologic agent for exanthem subitum (roseola), and it is well-known that central nervous system complications occur frequently during the course of HHV-6-associated disease. In addition, HHV-6 has been associated with encephalitis or encephalopathy. However, very little is known about its tropism for neural cells. There are reports that HHV-6 may infect some glial cell lines, but whether it can infect any primary neural cells is not known. Our studies show that both HHV-6A (GS) and HHV-6B (Z-29) can infect highly purified primary fetal astrocytes in vitro. Infected cells showed cytopathic effects, forming giant syncytia. In dual immunofluorescence assays, the infected cells were detected by antibodies against the HHV-6 p41 nuclear antigen and glial fibrillary acidic protein, indicating that the infected cells are indeed astrocytes. PCR and Northern (RNA) blot analyses also confirmed that the astrocytes are infected by HHV-6. The progeny virus did not alter its host range and could reinfect T cells as well as primary astrocytes. These findings suggest that infection of primary human astrocytes may play a role in the neuropathogenesis of HHV-6.

Full Text

The Full Text of this article is available as a PDF (942.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ablashi D. V., Josephs S. F., Buchbinder A., Hellman K., Nakamura S., Llana T., Lusso P., Kaplan M., Dahlberg J., Memon S. Human B-lymphotropic virus (human herpesvirus-6). J Virol Methods. 1988 Sep;21(1-4):29–48. doi: 10.1016/0166-0934(88)90050-x. [DOI] [PubMed] [Google Scholar]
  2. Ablashi D. V., Lusso P., Hung C. L., Salahuddin S. Z., Josephs S. F., Llana T., Kramarsky B., Biberfeld P., Markham P. D., Gallo R. C. Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (human herpesvirus 6). Int J Cancer. 1988 Nov 15;42(5):787–791. doi: 10.1002/ijc.2910420526. [DOI] [PubMed] [Google Scholar]
  3. Asano Y., Yoshikawa T., Kajita Y., Ogura R., Suga S., Yazaki T., Nakashima T., Yamada A., Kurata T. Fatal encephalitis/encephalopathy in primary human herpesvirus-6 infection. Arch Dis Child. 1992 Dec;67(12):1484–1485. doi: 10.1136/adc.67.12.1484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Black J. B., Sanderlin K. C., Goldsmith C. S., Gary H. E., Lopez C., Pellett P. E. Growth properties of human herpesvirus-6 strain Z29. J Virol Methods. 1989 Nov;26(2):133–145. doi: 10.1016/0166-0934(89)90143-2. [DOI] [PubMed] [Google Scholar]
  5. Carrigan D. R., Knox K. K., Tapper M. A. Suppression of human immunodeficiency virus type 1 replication by human herpesvirus-6. J Infect Dis. 1990 Oct;162(4):844–851. doi: 10.1093/infdis/162.4.844. [DOI] [PubMed] [Google Scholar]
  6. Caserta M. T., Hall C. B., Schnabel K., McIntyre K., Long C., Costanzo M., Dewhurst S., Insel R., Epstein L. G. Neuroinvasion and persistence of human herpesvirus 6 in children. J Infect Dis. 1994 Dec;170(6):1586–1589. doi: 10.1093/infdis/170.6.1586. [DOI] [PubMed] [Google Scholar]
  7. Challoner P. B., Smith K. T., Parker J. D., MacLeod D. L., Coulter S. N., Rose T. M., Schultz E. R., Bennett J. L., Garber R. L., Chang M. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7440–7444. doi: 10.1073/pnas.92.16.7440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chang C. K., Balachandran N. Identification, characterization, and sequence analysis of a cDNA encoding a phosphoprotein of human herpesvirus 6. J Virol. 1991 Jun;65(6):2884–2894. doi: 10.1128/jvi.65.6.2884-2894.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dewhurst S., McIntyre K., Schnabel K., Hall C. B. Human herpesvirus 6 (HHV-6) variant B accounts for the majority of symptomatic primary HHV-6 infections in a population of U.S. infants. J Clin Microbiol. 1993 Feb;31(2):416–418. doi: 10.1128/jcm.31.2.416-418.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Drobyski W. R., Knox K. K., Majewski D., Carrigan D. R. Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. N Engl J Med. 1994 May 12;330(19):1356–1360. doi: 10.1056/NEJM199405123301905. [DOI] [PubMed] [Google Scholar]
  11. Ensoli B., Lusso P., Schachter F., Josephs S. F., Rappaport J., Negro F., Gallo R. C., Wong-Staal F. Human herpes virus-6 increases HIV-1 expression in co-infected T cells via nuclear factors binding to the HIV-1 enhancer. EMBO J. 1989 Oct;8(10):3019–3027. doi: 10.1002/j.1460-2075.1989.tb08452.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Geng Y. Q., Chandran B., Josephs S. F., Wood C. Identification and characterization of a human herpesvirus 6 gene segment that trans activates the human immunodeficiency virus type 1 promoter. J Virol. 1992 Mar;66(3):1564–1570. doi: 10.1128/jvi.66.3.1564-1570.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gompels U. A., Nicholas J., Lawrence G., Jones M., Thomson B. J., Martin M. E., Efstathiou S., Craxton M., Macaulay H. A. The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution. Virology. 1995 May 10;209(1):29–51. doi: 10.1006/viro.1995.1228. [DOI] [PubMed] [Google Scholar]
  14. Hall C. B., Long C. E., Schnabel K. C., Caserta M. T., McIntyre K. M., Costanzo M. A., Knott A., Dewhurst S., Insel R. A., Epstein L. G. Human herpesvirus-6 infection in children. A prospective study of complications and reactivation. N Engl J Med. 1994 Aug 18;331(7):432–438. doi: 10.1056/NEJM199408183310703. [DOI] [PubMed] [Google Scholar]
  15. Horvat R. T., Wood C., Balachandran N. Transactivation of human immunodeficiency virus promoter by human herpesvirus 6. J Virol. 1989 Feb;63(2):970–973. doi: 10.1128/jvi.63.2.970-973.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Human herpesvirus-6 strain groups: a nomenclature. Arch Virol. 1993;129(1-4):363–366. doi: 10.1007/BF01316913. [DOI] [PubMed] [Google Scholar]
  17. Knox K. K., Carrigan D. R. Active human herpesvirus (HHV-6) infection of the central nervous system in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 May 1;9(1):69–73. [PubMed] [Google Scholar]
  18. Knox K. K., Harrington D. P., Carrigan D. R. Fulminant human herpesvirus six encephalitis in a human immunodeficiency virus-infected infant. J Med Virol. 1995 Mar;45(3):288–292. doi: 10.1002/jmv.1890450309. [DOI] [PubMed] [Google Scholar]
  19. Kondo K., Nagafuji H., Hata A., Tomomori C., Yamanishi K. Association of human herpesvirus 6 infection of the central nervous system with recurrence of febrile convulsions. J Infect Dis. 1993 May;167(5):1197–1200. doi: 10.1093/infdis/167.5.1197. [DOI] [PubMed] [Google Scholar]
  20. Levy J. A., Landay A., Lennette E. T. Human herpesvirus 6 inhibits human immunodeficiency virus type 1 replication in cell culture. J Clin Microbiol. 1990 Oct;28(10):2362–2364. doi: 10.1128/jcm.28.10.2362-2364.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Luppi M., Barozzi P., Maiorana A., Marasca R., Torelli G. Human herpesvirus 6 infection in normal human brain tissue. J Infect Dis. 1994 Apr;169(4):943–944. doi: 10.1093/infdis/169.4.943. [DOI] [PubMed] [Google Scholar]
  22. Lusso P., Malnati M. S., Garzino-Demo A., Crowley R. W., Long E. O., Gallo R. C. Infection of natural killer cells by human herpesvirus 6. Nature. 1993 Apr 1;362(6419):458–462. doi: 10.1038/362458a0. [DOI] [PubMed] [Google Scholar]
  23. McCarthy M., Wood C., Fedoseyeva L., Whittemore S. R. Media components influence viral gene expression assays in human fetal astrocyte cultures. J Neurovirol. 1995 Sep;1(3-4):275–285. doi: 10.3109/13550289509114024. [DOI] [PubMed] [Google Scholar]
  24. Pfeiffer B., Thomson B., Chandran B. Identification and characterization of a cDNA derived from multiple splicing that encodes envelope glycoprotein gp105 of human herpesvirus 6. J Virol. 1995 Jun;69(6):3490–3500. doi: 10.1128/jvi.69.6.3490-3500.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Pruksananonda P., Hall C. B., Insel R. A., McIntyre K., Pellett P. E., Long C. E., Schnabel K. C., Pincus P. H., Stamey F. R., Dambaugh T. R. Primary human herpesvirus 6 infection in young children. N Engl J Med. 1992 May 28;326(22):1445–1450. doi: 10.1056/NEJM199205283262201. [DOI] [PubMed] [Google Scholar]
  26. Saito Y., Sharer L. R., Dewhurst S., Blumberg B. M., Hall C. B., Epstein L. G. Cellular localization of human herpesvirus-6 in the brains of children with AIDS encephalopathy. J Neurovirol. 1995 Mar;1(1):30–39. doi: 10.3109/13550289509111008. [DOI] [PubMed] [Google Scholar]
  27. Salahuddin S. Z., Ablashi D. V., Markham P. D., Josephs S. F., Sturzenegger S., Kaplan M., Halligan G., Biberfeld P., Wong-Staal F., Kramarsky B. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science. 1986 Oct 31;234(4776):596–601. doi: 10.1126/science.2876520. [DOI] [PubMed] [Google Scholar]
  28. Sieczkowski L., Chandran B., Wood C. The human immunodeficiency virus tat gene enhances replication of human herpesvirus-6. Virology. 1995 Aug 20;211(2):544–553. doi: 10.1006/viro.1995.1436. [DOI] [PubMed] [Google Scholar]
  29. Sola P., Merelli E., Marasca R., Poggi M., Luppi M., Montorsi M., Torelli G. Human herpesvirus 6 and multiple sclerosis: survey of anti-HHV-6 antibodies by immunofluorescence analysis and of viral sequences by polymerase chain reaction. J Neurol Neurosurg Psychiatry. 1993 Aug;56(8):917–919. doi: 10.1136/jnnp.56.8.917. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Suga S., Yoshikawa T., Asano Y., Kozawa T., Nakashima T., Kobayashi I., Yazaki T., Yamamoto H., Kajita Y., Ozaki T. Clinical and virological analyses of 21 infants with exanthem subitum (roseola infantum) and central nervous system complications. Ann Neurol. 1993 Jun;33(6):597–603. doi: 10.1002/ana.410330607. [DOI] [PubMed] [Google Scholar]
  31. Wilborn F., Schmidt C. A., Brinkmann V., Jendroska K., Oettle H., Siegert W. A potential role for human herpesvirus type 6 in nervous system disease. J Neuroimmunol. 1994 Jan;49(1-2):213–214. doi: 10.1016/0165-5728(94)90198-8. [DOI] [PubMed] [Google Scholar]
  32. Yamanishi K., Okuno T., Shiraki K., Takahashi M., Kondo T., Asano Y., Kurata T. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet. 1988 May 14;1(8594):1065–1067. doi: 10.1016/s0140-6736(88)91893-4. [DOI] [PubMed] [Google Scholar]
  33. Yoshikawa T., Nakashima T., Suga S., Asano Y., Yazaki T., Kimura H., Morishima T., Kondo K., Yamanishi K. Human herpesvirus-6 DNA in cerebrospinal fluid of a child with exanthem subitum and meningoencephalitis. Pediatrics. 1992 May;89(5 Pt 1):888–890. [PubMed] [Google Scholar]
  34. Zhou Y., Chang C. K., Qian G., Chandran B., Wood C. trans-activation of the HIV promoter by a cDNA and its genomic clones of human herpesvirus-6. Virology. 1994 Mar;199(2):311–322. doi: 10.1006/viro.1994.1129. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES